Noema Pharma Ag
Clinical trials sponsored by Noema Pharma Ag, explained in plain language.
-
New hope for face pain sufferers: drug trial targets trigeminal neuralgia
Symptom relief OngoingThis study tests a daily drug called basimglurant in 166 adults with trigeminal neuralgia, a condition causing severe facial pain. Participants have not gotten enough relief from their current pain medicines. The trial checks if the drug can reduce pain attacks and improve qualit…
Phase: PHASE2, PHASE3 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated May 19, 2026 12:01 UTC
-
New pill aims to quiet tics in tourette syndrome
Symptom relief OngoingThis study tests a new medicine called gemlapodect to see if it can safely reduce tics (unwanted movements or sounds) in people with Tourette syndrome. About 164 adults and teenagers with moderate to severe tics will receive either the drug or a placebo for 12 weeks. The main goa…
Phase: PHASE2 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC